feed,title,long_url,short_url
Benzinga,"With Over 400% Upside, This Cancer Stock Offers 'Attractive Entry Point To Long-Term Investors,' Analyst Says",https://benzinga.com/general/biotech/22/08/28689545/with-over-400-upside-hc-wainwright-says-this-cancer-stock-offers-attractive-entry-point-to-long-t,https://bit.ly/3AUrW0V
